Teglutik

Teglutik (riluzole) is a prescription medication used for amyotrophic lateral sclerosis (ALS) management. It helps slow disease progression by protecting nerve cells. This oral suspension offers convenient administration for patients requiring neuroprotective therapy.

Teglutik (riluzole) is prescribed to slow the progression of amyotrophic lateral sclerosis (ALS), a condition affecting nerve cells in the brain and spinal cord. It is used in adults to extend survival time and delay the need for ventilatory support. Patients and caregivers often ask what Teglutik is used for in ALS treatment.

Teglutik (riluzole) works by reducing the release of glutamate, a chemical that can damage nerve cells. This helps maintain nerve function over time. Users may notice improved stability in daily activities as the condition progresses. The effects are gradual and vary by individual response.

Teglutik (riluzole) should be stored at room temperature and protected from light. It is important to follow the prescribed administration schedule to maintain consistent levels in the body. Patients should report any unusual symptoms to their healthcare provider promptly. Regular monitoring may be required during treatment.

Teglutik (riluzole) may interact with medications that affect liver enzymes, such as certain antidepressants or antifungals. Alcohol and tobacco use can influence its effectiveness and side effects. Patients should inform their doctor about all current medications and lifestyle habits before starting Teglutik.